OBJECTIVE: Insulin resistance has been linked to intrauterine growth restriction; adiponectin is a strong determinant of insulin sensitivity. We aimed at studying the contributions of birthweight and insulin sensitivity to circulating adiponectin in children born small for gestational age (SGA). DESIGN: Cross-sectional, hospital-based study dealing with insulin sensitivity in SGA children. PATIENTS: Thirty-two prepubertal children born SGA (age 5.4 +/- 2.9 years) and 37 prepubertal children born appropriate for gestational age (AGA, age 5.9 +/- 3.0 years). MEASUREMENTS: Serum levels of fasting glucose, serum lipids, insulin (immunometric assay) and adiponectin concentrations (ELISA) were assessed, and insulin resistance (IR) and insulin secretion (beta-cell) were calculated by the homeostasis model of assessment (HOMA). RESULTS: SGA children had similar HOMA-IR, HOMA-beta-cell and adiponectin concentrations than AGA children. However, in a separate analysis of subjects older than 3 years of age, SGA children showed higher HOMA-IR after adjusting for sex, age and body mass index (BMI) standard deviation score (SDS). Circulating adiponectin was higher in SGA children [adjusted means: 14.5 mg/l (95% CI 12.9-16.1) and 18.7 mg/l (95% CI 17.0-20.3) for AGA and SGA children, respectively; P < 0.0001]. Further analysis revealed that the group of overweight SGA (arbitrarily defined as being in the higher quartile for the BMI SDS distribution in the sample) had decreased serum concentrations of adiponectin, compared to lean SGA children [adjusted means: 12.9 mg/l (95% CI 9.3-16.5) vs. 19.0 (95% CI 16.8-21.3), respectively; P = 0.001]. In a multiple regression model, HOMA-IR and SGA status explained 35% and 15% of adiponectin variance, respectively. CONCLUSIONS: Prenatal growth restriction is associated with insulin resistance but relatively increased adiponectin concentrations, provided overweight does not ensue. The contributions of circulating adiponectin to the increased risks for developing insulin resistance and type-2 diabetes in formerly SGA subjects merit further studies.
OBJECTIVE:Insulin resistance has been linked to intrauterine growth restriction; adiponectin is a strong determinant of insulin sensitivity. We aimed at studying the contributions of birthweight and insulin sensitivity to circulating adiponectin in children born small for gestational age (SGA). DESIGN: Cross-sectional, hospital-based study dealing with insulin sensitivity in SGA children. PATIENTS: Thirty-two prepubertal children born SGA (age 5.4 +/- 2.9 years) and 37 prepubertal children born appropriate for gestational age (AGA, age 5.9 +/- 3.0 years). MEASUREMENTS: Serum levels of fasting glucose, serum lipids, insulin (immunometric assay) and adiponectin concentrations (ELISA) were assessed, and insulin resistance (IR) and insulin secretion (beta-cell) were calculated by the homeostasis model of assessment (HOMA). RESULTS: SGA children had similar HOMA-IR, HOMA-beta-cell and adiponectin concentrations than AGA children. However, in a separate analysis of subjects older than 3 years of age, SGA children showed higher HOMA-IR after adjusting for sex, age and body mass index (BMI) standard deviation score (SDS). Circulating adiponectin was higher in SGA children [adjusted means: 14.5 mg/l (95% CI 12.9-16.1) and 18.7 mg/l (95% CI 17.0-20.3) for AGA and SGA children, respectively; P < 0.0001]. Further analysis revealed that the group of overweight SGA (arbitrarily defined as being in the higher quartile for the BMI SDS distribution in the sample) had decreased serum concentrations of adiponectin, compared to lean SGA children [adjusted means: 12.9 mg/l (95% CI 9.3-16.5) vs. 19.0 (95% CI 16.8-21.3), respectively; P = 0.001]. In a multiple regression model, HOMA-IR and SGA status explained 35% and 15% of adiponectin variance, respectively. CONCLUSIONS: Prenatal growth restriction is associated with insulin resistance but relatively increased adiponectin concentrations, provided overweight does not ensue. The contributions of circulating adiponectin to the increased risks for developing insulin resistance and type-2 diabetes in formerly SGA subjects merit further studies.
Authors: Elizabeth A DuPriest; Baoyu Lin; Philipp Kupfer; Kaiu Sekiguchi; Amruta Bhusari; Alexandra Quackenbush; Almir Celebic; Terry K Morgan; Jonathan Q Purnell; Susan P Bagby Journal: Am J Physiol Regul Integr Comp Physiol Date: 2018-06-20 Impact factor: 3.619
Authors: Frank T Spradley; Jillian A Smith; Barbara T Alexander; Christopher D Anderson Journal: Am J Physiol Endocrinol Metab Date: 2018-03-06 Impact factor: 4.310
Authors: E A DuPriest; P Kupfer; B Lin; K Sekiguchi; T K Morgan; K E Saunders; T T Chatkupt; O N Denisenko; J Q Purnell; S P Bagby Journal: J Dev Orig Health Dis Date: 2012-06 Impact factor: 2.401
Authors: Magnus H Fasting; Emily Oken; Christos S Mantzoros; Janet W Rich-Edwards; Joseph A Majzoub; Ken Kleinman; Sheryl L Rifas-Shiman; Torstein Vik; Matthew W Gillman Journal: J Clin Endocrinol Metab Date: 2009-02-03 Impact factor: 5.958
Authors: Tessa L Crume; Ann Scherzinger; Elizabeth Stamm; Robert McDuffie; Kimberly J Bischoff; Richard F Hamman; Dana Dabelea Journal: Obesity (Silver Spring) Date: 2013-09-17 Impact factor: 5.002
Authors: Silvia Visentin; Annunziata Lapolla; Ambrogio Pietro Londero; Chiara Cosma; Mariagrazia Dalfrà; Martina Camerin; Diego Faggian; Mario Plebani; Erich Cosmi Journal: Biomed Res Int Date: 2014-06-22 Impact factor: 3.411
Authors: Anna S Challa; Eleni N Evagelidou; Vasilios I Cholevas; Dimitrios N Kiortsis; Vasileios I Giapros; Aikaterini A Drougia; Styliani K Andronikou Journal: Diabetes Care Date: 2009-01-08 Impact factor: 17.152